Evidence map›Paper›PMID 39061338›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Antimicrobial Resistance Surveillance: Data Harmonisation and Data Selection within Secondary Data Use.

Sinja Bleischwitz, Tristan Salomon Winkelmann, Yvonne Pfeifer, Martin Alexander Fischer, Niels Pfennigwerth, Jens André Hammerl, Ulrike Binsker, Jörg B Hans, Sören Gatermann, Annemarie Käsbohrer and 2 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sinja BleischwitzDepartment of Biometry, Epidemiology and Information Processing, WHO Collaborating Centre for Research and Training for Health in the Human-Animal-Environment Interface, University for Veterinary Medicine, 30559 Hanover, Germany.
Tristan Salomon WinkelmannDepartment of Biometry, Epidemiology and Information Processing, WHO Collaborating Centre for Research and Training for Health in the Human-Animal-Environment Interface, University for Veterinary Medicine, 30559 Hanover, Germany.ORCID 0009-0003-4857-8610
Yvonne PfeiferDepartment of Infectious Diseases, Division of Nosocomial Pathogens and Antimicrobial Resistances, Robert Koch Institute, 38855 Wernigerode, Germany.
Martin Alexander FischerDepartment of Infectious Diseases, Division of Nosocomial Pathogens and Antimicrobial Resistances, Robert Koch Institute, 38855 Wernigerode, Germany.
Niels PfennigwerthNational Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Department Medical Microbiology, Ruhr-University Bochum, 44801 Bochum, Germany.ORCID 0000-0002-6403-5646
Jens André HammerlDivision of Epidemiology, Zoonoses and Antimicrobial Resistance, Department Biological Safety, Federal Institute for Risk Assessment, 12277 Berlin, Germany.ORCID 0000-0002-6930-4358
Ulrike BinskerDivision of Epidemiology, Zoonoses and Antimicrobial Resistance, Department Biological Safety, Federal Institute for Risk Assessment, 12277 Berlin, Germany.ORCID 0000-0002-1963-1916
Jörg B HansNational Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Department Medical Microbiology, Ruhr-University Bochum, 44801 Bochum, Germany.
Sören GatermannNational Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Department Medical Microbiology, Ruhr-University Bochum, 44801 Bochum, Germany.
Annemarie KäsbohrerDivision of Epidemiology, Zoonoses and Antimicrobial Resistance, Department Biological Safety, Federal Institute for Risk Assessment, 12277 Berlin, Germany.ORCID 0000-0003-2966-2713
Guido WernerDepartment of Infectious Diseases, Division of Nosocomial Pathogens and Antimicrobial Resistances, Robert Koch Institute, 38855 Wernigerode, Germany.
Lothar KreienbrockDepartment of Biometry, Epidemiology and Information Processing, WHO Collaborating Centre for Research and Training for Health in the Human-Animal-Environment Interface, University for Veterinary Medicine, 30559 Hanover, Germany.

Funding

German Minister for Health zMVtl -2518FS8707
6 · The paper itself

Abstract

Resistance to last-resort antibiotics is a global threat to public health. Therefore, surveillance and monitoring systems for antimicrobial resistance should be established on a national and international scale. For the development of a One Health surveillance system, we collected exemplary data on carbapenem and colistin-resistant bacterial isolates from human, animal, food, and environmental sources. We pooled secondary data from routine screenings, hospital outbreak investigations, and studies on antimicrobial resistance. For a joint One Health evaluation, this study incorporates epidemiological metadata with phenotypic resistance information and molecular data on the isolate level. To harmonise the heterogeneous original information for the intended use, we developed a generic strategy. By defining and categorising variables, followed by plausibility checks, we created a catalogue for prospective data collections and applied it to our dataset, enabling us to perform preliminary descriptive statistical analyses. This study shows the complexity of data management using heterogeneous secondary data pools and gives an insight into the early stages of the development of an AMR surveillance programme using secondary data.

Indexed as

carbapenemcluster analysiscolistindata collectionEnterobacteriaceaemcr-1molecular surveillancemultidrug resistanceOne Health

Identifiers

PMID39061338
PMCPMC11273461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.